Free Trial

Albemarle Corporation $ALB Shares Acquired by Kovitz Investment Group Partners LLC

Albemarle logo with Basic Materials background

Key Points

  • Kovitz Investment Group Partners LLC raised its stake in Albemarle Corporation by 314.3%, acquiring a total of 83,374 shares valued at approximately $6 million.
  • Albemarle reported a quarterly earnings per share of $0.11, exceeding expectations, but its revenue decreased by 7.0% compared to the previous year.
  • Analysts have issued mixed ratings on Albemarle's stock, with five analysts rating it as a sell, while the consensus price target is $88.06.
  • MarketBeat previews top five stocks to own in October.

Kovitz Investment Group Partners LLC raised its stake in shares of Albemarle Corporation (NYSE:ALB - Free Report) by 314.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 83,374 shares of the specialty chemicals company's stock after purchasing an additional 63,248 shares during the period. Kovitz Investment Group Partners LLC owned 0.07% of Albemarle worth $6,005,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Albemarle by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 14,672,272 shares of the specialty chemicals company's stock worth $1,056,697,000 after buying an additional 77,773 shares in the last quarter. ProShare Advisors LLC lifted its position in Albemarle by 1.3% in the fourth quarter. ProShare Advisors LLC now owns 1,990,762 shares of the specialty chemicals company's stock worth $171,365,000 after buying an additional 25,207 shares during the last quarter. Earnest Partners LLC boosted its stake in Albemarle by 0.6% during the fourth quarter. Earnest Partners LLC now owns 1,432,153 shares of the specialty chemicals company's stock worth $123,280,000 after buying an additional 8,243 shares during the period. Northern Trust Corp increased its position in Albemarle by 12.1% during the fourth quarter. Northern Trust Corp now owns 1,290,797 shares of the specialty chemicals company's stock valued at $111,112,000 after acquiring an additional 139,600 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Albemarle by 1.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,195,496 shares of the specialty chemicals company's stock worth $102,910,000 after acquiring an additional 14,603 shares during the last quarter. 92.87% of the stock is owned by institutional investors.

Albemarle Stock Up 3.0%

Shares of Albemarle stock traded up $2.3530 during trading on Friday, reaching $81.2930. The company's stock had a trading volume of 1,362,296 shares, compared to its average volume of 3,549,523. Albemarle Corporation has a 1-year low of $49.43 and a 1-year high of $113.91. The company has a 50-day simple moving average of $70.86 and a two-hundred day simple moving average of $67.97. The company has a quick ratio of 1.47, a current ratio of 2.31 and a debt-to-equity ratio of 0.38. The company has a market cap of $9.57 billion, a price-to-earnings ratio of -8.75 and a beta of 1.63.

Albemarle (NYSE:ALB - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $0.11 EPS for the quarter, topping the consensus estimate of ($0.83) by $0.94. Albemarle had a negative net margin of 18.61% and a negative return on equity of 1.87%. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.23 billion. During the same period in the previous year, the firm posted $0.04 earnings per share. The business's revenue for the quarter was down 7.0% compared to the same quarter last year. Albemarle has set its FY 2025 guidance at EPS. As a group, equities analysts forecast that Albemarle Corporation will post -0.04 earnings per share for the current year.

Albemarle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, September 12th will be issued a $0.405 dividend. This represents a $1.62 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Friday, September 12th. Albemarle's payout ratio is presently -17.38%.

Wall Street Analysts Forecast Growth

ALB has been the subject of several analyst reports. Mizuho set a $76.00 price objective on shares of Albemarle in a research note on Tuesday, July 15th. UBS Group lifted their price objective on shares of Albemarle from $57.00 to $62.00 and gave the company a "sell" rating in a report on Thursday, July 31st. JPMorgan Chase & Co. lifted their price target on shares of Albemarle from $60.00 to $80.00 and gave the company a "neutral" rating in a research note on Monday. Baird R W downgraded Albemarle from a "hold" rating to a "strong sell" rating in a report on Tuesday, July 29th. Finally, Piper Sandler set a $68.00 price target on Albemarle and gave the stock an "underweight" rating in a research report on Wednesday, May 14th. Three research analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Reduce" and a consensus price target of $89.17.

Read Our Latest Stock Report on ALB

Albemarle Profile

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Read More

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Should You Invest $1,000 in Albemarle Right Now?

Before you consider Albemarle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.

While Albemarle currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

He Said Sell Oracle. Here’s What Happened Next.
Forget Earnings Hype: 2 Must-Buy Stocks and 2 to Dump
AMD’s 2026 Forecasts Are Way Too Low

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines